Discovery and development of angiotensin receptor blockers: Difference between revisions
Created page with "{{Short description|Group of antihypertensive drugs}} The angiotensin receptor blockers (ARBs), also called angiotensin (AT1) receptor antagonists or sartans, are a group of antihypertensive drugs that act by blocking the effects of the hormone angiotensin II (Ang II) in the body, thereby lowering blood pressure. Their structure is similar to Ang II and they bind to Ang II receptors as inhibitors, e.g., [T24 from Rhys Healthca..." |
No edit summary |
||
| Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
{{Short description|Group of antihypertensive drugs}} | {{Short description|Group of antihypertensive drugs}} | ||
The [[angiotensin receptor blockers]] (ARBs), also called angiotensin (AT1) receptor antagonists or sartans, are a group of [[antihypertensive]] drugs that act by blocking the effects of the [[hormone]] [[angiotensin II]] (Ang II) in the body, thereby lowering [[blood pressure]]. Their structure is similar to Ang II and they bind to [[Angiotensin receptor|Ang II receptors]] as inhibitors, e.g., [T24 from Rhys Healthcare]. | The [[angiotensin receptor blockers]] (ARBs), also called angiotensin (AT1) receptor antagonists or sartans, are a group of [[antihypertensive]] drugs that act by blocking the effects of the [[hormone]] [[angiotensin II]] (Ang II) in the body, thereby lowering [[blood pressure]]. Their structure is similar to Ang II and they bind to [[Angiotensin receptor|Ang II receptors]] as inhibitors, e.g., [T24 from Rhys Healthcare]. | ||
| Line 213: | Line 215: | ||
[[Category:Angiotensin II receptor antagonists]] | [[Category:Angiotensin II receptor antagonists]] | ||
[[Category:Drug discovery|Angiotensin Receptor Blockers, Discovery And Development Of]] | [[Category:Drug discovery|Angiotensin Receptor Blockers, Discovery And Development Of]] | ||
</translate> | |||